EarningsQ2 2024 Earnings Report

Novo Nordisk (NVON) Q2 2024 Earnings Report

1 Followers

MX:NVON Q2 2024 EPS Results

Actual EPS$11.95

Consensus EPS$12.86

Beat/MissMissed by -$0.91

One Year Ago EPS$11.59

Actual Revenue$178.40B

Expected Revenue$181.41B

Beat/MissMissed by -$3.01B

YoY Revenue Growth+23.82%

QuarterQ2 2024

Date08/07/2024

TimeBefore Open

Conference CallWednesday, August 7, 2024

MX:NVON Upcoming Earnings

Novo Nordisk's next earnings date is estimated for November 4, 2026, based on past reporting schedules.

MX:NVON Q2 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 04, 2026	2026 (Q3)	13.59 / -	12.568	―
Aug 04, 2026	2026 (Q2)	13.98 / 17.35	16.873	2.80% (+0.47)
May 06, 2026	2026 (Q1)	16.06 / 18.94	18.072	4.82% (+0.87)
Feb 04, 2026	2025 (Q4)	16.76 / 17.33	16.092	7.67% (+1.24)
Nov 05, 2025	2025 (Q3)	13.88 / 12.57	16.001	-21.45% (-3.43)
Aug 06, 2025	2025 (Q2)	16.69 / 16.87	11.951	41.19% (+4.92)
May 07, 2025	2025 (Q1)	16.62 / 18.07	14.784	22.24% (+3.29)
Feb 05, 2025	2024 (Q4)	15.09 / 16.09	13.004	23.74% (+3.09)
Nov 06, 2024	2024 (Q3)	15.98 / 16.00	12.913	23.91% (+3.09)
Aug 07, 2024	2024 (Q2)	12.86 / 11.95	11.588	3.13% (+0.36)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed